Today for the first time we will celebrate World Pulmonary Hypertension Day!
Pulmonary hypertension is characterized by elevated pulmonary arterial pressure and secondary right ventricular failure. It is a life-threatening condition with a poor prognosis if untreated. The symptoms of PAH are nonspecific and include breathlessness, fatigue, weakness, angina, syncope and abdominal distension.
The Spanish National Pulmonary Hypertension Association proposed May 5 as World Pulmonary Hypertension Day to increase international awareness of the disease. On May 4 and 5, the ANHP will organize scientific symposia on pharmacological treatments, PH registers, and multidisciplinary support for patients.
The ANHP aims to use the day to “disseminate knowledge of the disease to facilitate early diagnosis, promote access to specific healthcare and treatments that increase quality of life and life expectancy, promote the concept of treating PH patients as a whole— which includes treating their physical, psychological, and social issues—unify international criteria for the recognition of Centers of Excellence in PH, and promote research that will help find a cure for PH.”
These days I am participating at International Conference which is dedicated to World Pulmonary Hypertension Day with launch of Romanian National Program for the diagnosis and treatment of Pulmonary Hypertension at Iasi, Romania.